Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML.
Duchmann M, Wagner-Ballon O, Boyer T, Cheok M, Fournier E, Guerin E, Fenwarth L, Badaoui B, Freynet N, Benayoun E, Lusina D, Garcia I, Gardin C, Fenaux P, Pautas C, Quesnel B, Turlure P, Terré C, Thomas X, Lambert J, Renneville A, Preudhomme C, Dombret H, Itzykson R, Cluzeau T.
Duchmann M, et al. Among authors: garcia i.
Leukemia. 2022 Mar;36(3):656-663. doi: 10.1038/s41375-021-01435-7. Epub 2021 Oct 6.
Leukemia. 2022.
PMID: 34615986
Clinical Trial.